Metformin, the remarkable and unique antidiabetic agent
In the current issue of this Journal, Fiad and colleagues thoughtfully reviewed in detail the role of metformin in current clinical practice and highlighted the additional effects of metformin independent of the glycemic action of the drug. The review is comprehensive, up to date and is extensively supported by the literature. Metformin remains the first drug of choice in patients diagnosed with type 2 diabetes. Its vascular protection actions are particularly interesting though not yet fully understood. Its antineoplastic actions are very exciting. The authors clarify the issues of gastrointestinal side effects and renal limitations of its use and give practical ways of minimizing the potential loss of benefit to all treated patients.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Metformin, the remarkable and unique antidiabetic agent ; volume:05 ; number:04 ; year:2013 ; pages:240-242
Ibnosina journal of medicine and biomedical sciences ; 05, Heft 04 (2013), 240-242
- Beteiligte Personen und Organisationen
-
Lakhdar, Abdulfattah
- DOI
-
10.4103/1947-489X.210551
- URN
-
urn:nbn:de:101:1-2022101002333403132590
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lakhdar, Abdulfattah